The GLP-1 and hair thinning connection
Significant weight loss in obese/overweight people was demonstrated for liraglutide versus placebo in populations with and without T2D in the SCALE trials (Davies et al, 2015
These drugs, also being studied for treating substance use disorders, can be transformative but remain costly, averaging nearly $1,000 monthly without insurance
Of note, only small number of sudies investigated this outcome with heterogenity in inclusion criteria among study populations, and differences in AOX combinations and SDF assays used
Consider meal timing: Since Semaglutide can affect appetite and digestion, plan your injection around a time when you can still eat balanced meals and stay hydrated
adults are considered obese, and with traditional weight loss strategies like diet and exercise proving insufficient for many, physicians are increasingly turning to medication as an adjunct treatment